Klaus Weinberger co-invented one of the first real-time PCR assays used in diagnostic labs across Europe. He never patented it. He never made a dime. That was just the beginning.

What followed was three decades of building in life science diagnostics. A sabotaged patient database. A toxic board member who cost two years of runway. A company sold after nine years with deeply mixed feelings. A funding system that rewards drugs extending suffering over diagnostics that could prevent it entirely. Klaus survived all of it. He is still building.

In this episode Klaus talks about what conviction actually costs in a field where the timelines are long, the capital is scarce, and being scientifically right is not always enough to survive commercially. He does not offer a clean narrative. He offers the truth of what three decades in this industry actually looks like from the inside.

For founders, investors, and executives working in life science diagnostics, medtech, and biotech who want the conversation that nobody else is having out loud.

Willing to Win – Biotech Leaders Against All Odds is hosted by Christian Rados, founder of Rados Recruiting, an executive search firm focused on life sciences.